Over the last decade, WCE has established itself as a valuable test for imaging the small intestine. It is a safe and relatively easy procedure to perform that can provide valuable information in the diagnosis of small-bowel conditions. Its applications still remain limited within the esophagus and colon. Future developments may include improving visualization within the esophagus and developing technologies that may allow manipulation of the capsule within the GI tract and biopsy capabilities.
Keywords: DBE; FDA; Food and Drug Administration; NSAID; OGIB; WCE; double-balloon endoscopy; nonsteroidal anti-inflammatory drug; obscure GI bleeding; wireless capsule endoscopy.